EGFR-IN-33 is a selective inhibitor of the epidermal growth factor receptor (EGFR), designed to target aberrant signaling pathways associated with tumor growth. This acrylamide derivative exhibits significant anti-tumor activity while maintaining low toxicity profiles. EGFR-IN-33 is particularly relevant for research focusing on cancers driven by EGFR mutations and overexpression, including non-small cell lung cancer (NSCLC). Its potential utility in elucidating the mechanisms of EGFR-related malignancies establishes it as a valuable tool in cancer research.
EGFR-IN-33 is a selective inhibitor of the epidermal growth factor receptor (EGFR), designed to target aberrant signaling pathways associated with tumor growth. This acrylamide derivative exhibits significant anti-tumor activity while maintaining low toxicity profiles. EGFR-IN-33 is particularly relevant for research focusing on cancers driven by EGFR mutations and overexpression, including non-small cell lung cancer (NSCLC). Its potential utility in elucidating the mechanisms of EGFR-related malignancies establishes it as a valuable tool in cancer research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: